Talaris Therapeutics Inc

-0.16 (-1.78%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Talaris Therapeutics Inc Stock, NASDAQ:TALS

570 South Preston Street, Louisville, Kentucky 40202
United States of America
Phone: +1.502.398.9250
Number of Employees: 90


Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its technologies are used to treat inherited metabolic enzyme disorders, red blood cell disorders to induce tolerance to organ transplants, and to treat autoimmune disorders such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The company was founded by Suzanne Ildstad in 2002 and is headquartered in Louisville, KY.